229 related articles for article (PubMed ID: 31051235)
1. ABC transporters in drug-resistant epilepsy: mechanisms of upregulation and therapeutic approaches.
Leandro K; Bicker J; Alves G; Falcão A; Fortuna A
Pharmacol Res; 2019 Jun; 144():357-376. PubMed ID: 31051235
[TBL] [Abstract][Full Text] [Related]
2. ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
Lazarowski A; Czornyj L; Lubienieki F; Girardi E; Vazquez S; D'Giano C
Epilepsia; 2007; 48 Suppl 5():140-9. PubMed ID: 17910594
[TBL] [Abstract][Full Text] [Related]
3. Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected.
Löscher W; Luna-Tortós C; Römermann K; Fedrowitz M
Curr Pharm Des; 2011; 17(26):2808-28. PubMed ID: 21827408
[TBL] [Abstract][Full Text] [Related]
4. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.
Löscher W; Potschka H
NeuroRx; 2005 Jan; 2(1):86-98. PubMed ID: 15717060
[TBL] [Abstract][Full Text] [Related]
5. Research Progress on the Role of ABC Transporters in the Drug Resistance Mechanism of Intractable Epilepsy.
Xiong J; Mao DA; Liu LQ
Biomed Res Int; 2015; 2015():194541. PubMed ID: 26491660
[TBL] [Abstract][Full Text] [Related]
6. Ontogeny of ABC and SLC transporters in the microvessels of developing rat brain.
Soares RV; Do TM; Mabondzo A; Pons G; Chhun S
Fundam Clin Pharmacol; 2016 Apr; 30(2):107-16. PubMed ID: 26662930
[TBL] [Abstract][Full Text] [Related]
7. Dysfunction of ABC Transporters at the Surface of BBB: Potential Implications in Intractable Epilepsy and Applications of Nanotechnology Enabled Drug Delivery.
Mohi-Ud-Din R; Mir RH; Mir PA; Banday N; Shah AJ; Sawhney G; Bhat MM; Batiha GE; Pottoo FH
Curr Drug Metab; 2022; 23(9):735-756. PubMed ID: 35980054
[TBL] [Abstract][Full Text] [Related]
8. Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance.
Grewal GK; Kukal S; Kanojia N; Saso L; Kukreti S; Kukreti R
Molecules; 2017 Feb; 22(3):. PubMed ID: 28264441
[TBL] [Abstract][Full Text] [Related]
9. Drug transporters in the epileptic brain.
Löscher W
Epilepsia; 2007; 48 Suppl 1():8-13. PubMed ID: 17316407
[TBL] [Abstract][Full Text] [Related]
10. Exploring the possible interaction between anti-epilepsy drugs and multidrug efflux pumps; in vitro observations.
Rivers F; O'Brien TJ; Callaghan R
Eur J Pharmacol; 2008 Nov; 598(1-3):1-8. PubMed ID: 18835265
[TBL] [Abstract][Full Text] [Related]
11. Transporter hypothesis of drug-resistant epilepsy: challenges for pharmacogenetic approaches.
Potschka H
Pharmacogenomics; 2010 Oct; 11(10):1427-38. PubMed ID: 21047204
[TBL] [Abstract][Full Text] [Related]
12. Effect of Neuroinflammation on ABC Transporters: Possible Contribution to Refractory Epilepsy.
Deng X; Xie Y; Chen Y
CNS Neurol Disord Drug Targets; 2018; 17(10):728-735. PubMed ID: 30152292
[TBL] [Abstract][Full Text] [Related]
13. ABC Transporters and Drug Resistance in Patients with Epilepsy.
Feldmann M; Koepp M
Curr Pharm Des; 2016; 22(38):5793-5807. PubMed ID: 27514707
[TBL] [Abstract][Full Text] [Related]
14. Lack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy.
Soranzo N; Kelly L; Martinian L; Burley MW; Thom M; Sali A; Kroetz DL; Goldstein DB; Sisodiya SM
Epilepsia; 2007 Apr; 48(4):674-83. PubMed ID: 17437410
[TBL] [Abstract][Full Text] [Related]
15. Role of CNS efflux drug transporters in antiepileptic drug delivery: overcoming CNS efflux drug transport.
Potschka H
Adv Drug Deliv Rev; 2012 Jul; 64(10):943-52. PubMed ID: 22210135
[TBL] [Abstract][Full Text] [Related]
16. Lack of interactions between breast cancer resistance protein (bcrp/abcg2) and selected antiepileptic agents.
Cerveny L; Pavek P; Malakova J; Staud F; Fendrich Z
Epilepsia; 2006 Mar; 47(3):461-8. PubMed ID: 16529607
[TBL] [Abstract][Full Text] [Related]
17. Drug resistance in epilepsy: the role of the blood-brain barrier.
Abbott NJ; Khan EU; Rollinson CM; Reichel A; Janigro D; Dombrowski SM; Dobbie MS; Begley DJ
Novartis Found Symp; 2002; 243():38-47; discussion 47-53, 180-5. PubMed ID: 11990780
[TBL] [Abstract][Full Text] [Related]
18. Clinical reappraisal of the influence of drug-transporter polymorphisms in epilepsy.
Orlandi A; Paolino MC; Striano P; Parisi P
Expert Opin Drug Metab Toxicol; 2018 May; 14(5):505-512. PubMed ID: 29804481
[TBL] [Abstract][Full Text] [Related]
19. Expression of ATP-binding cassette transporters at the inner blood-retinal barrier in a neonatal mouse model of oxygen-induced retinopathy.
Tagami M; Kusuhara S; Honda S; Tsukahara Y; Negi A
Brain Res; 2009 Aug; 1283():186-93. PubMed ID: 19505448
[TBL] [Abstract][Full Text] [Related]
20. A Novel Approach to Refractory Epilepsy by Targeting Pgp Peripherally and Centrally: Therapeutic Targets and Future Perspectives.
Langeh U; Chawla P; Gupta GD; Singh S
CNS Neurol Disord Drug Targets; 2020; 19(10):741-749. PubMed ID: 32814543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
